Sarah Weaver (Miller)

Sarah has over six years of corporate tax experience and works closely with companies in the technology and life science industries, specifically in the biotech, pharmaceutical, medical device, software, social media, communications and manufacturing sectors.

She primarily works with pre-revenue startups with IPO aspirations and consolidated, multinational publicly-traded corporations. Sarah has extensive experience with tax provisions and a variety of tax compliance matters, including domestic and international tax filings, multistate income tax, as well as federal and state credit incentives.

Sarah has guided multiple life science companies from startup to IPO, including tax planning for a successful business combination, collaboration agreements, multiple rounds of funding and global expansion.

She recently served as outsourced tax manager for one of BPM’s corporate clients during its annual audit and 10-K filing, Q1 audit and 10-Q filing, and review of its internal control narrative with three third-party accounting firms. She intimately know the demands of a tax manager and finance team.

Sarah’s background also includes advising clients on the impacts of recent tax law changes and changes in accounting principles, including adoption of ASC 606 and 842, in their provision for income taxes. Specifically, with COVID-19 beneficial legislation, she informed clients of the tax impacts of the Coronavirus Aid, Relief and Economic Security (CARES), Paycheck Protection Program (PPP), disaster relief payments to employees under IRC Section 139 and the deferral of employer payroll taxes.

In addition to serving her clients, Sarah actively participates in the Life Science Industry Group. She is also passionate about developing and mentoring staff.

Sarah Weaver holds an active CPA license in California.